Your Search Results

Aortic valve disease: guidelines and beyond

22 Nov 2021 – From PCR London Valves 2021

Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...

Aortic valve disease: guidelines and beyond

Mitral transcatheter edge-to-edge repair

22 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session dedicated to mitral transcatheter edge-to-edge repair will enable you to understand this specific therapy by the use of anatomical specimens, imaging, and simulations.

Transcatheter tricuspid valve interventions: prevention of complications and their management

22 Nov 2021 – From PCR London Valves 2021

Watch this session from PCR London Valves 2021 if you want to find out more about the complications you may encounter during transcatheter tricuspid valve procedures, learn more about how to schedule and prepare for these interventions to avoid complications, and get more tips and tricks...

Transcatheter tricuspid valve interventions: prevention of complications and their management

TAVI: the future

22 Nov 2021 – From PCR London Valves 2021

This session from PCR London Valves 2021 particularly focuses on the expected expansions of TAVI to patients at a younger age and with a longer life expectancy, including a virtual live case from Clinique Pasteur, Toulouse, France.

The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement

18 Sep 2022

Jonathan Curio provides his take on the PROTECTED TAVR study which was presented by Samir R. Kapadia at TCT 2022. The aim was to evaluate whether TAVR with cerebral embolic protection would reduce the rate of clinical stroke in transfemoral TAVR.

Author

Jonathan Curio

The PROTECTED TAVR study: Cerebral embolic protection during transcatheter aortic valve replacement

Outcomes in patients with atrial fibrillation randomized to receive LAA closure or oral anticoagulation: Primary results of the CHAMPION-AF clinical trial

28 Mar 2026

During the first Late-Breaking Trial session of the 2026 ACC Congress held in New Orleans, Saibal Kar, principal investigator of the CHAMPION-AF trial, presented the 3-year results of this groundbreaking study, which were simultaneously published in the NEJM (DOI: 10.1056/NEJMoa2517213).